COST-EFFECTIVENESS OF DAPAGLIFLOZIN IN THE TREATMENT OF CHRONIC SYMPTOMATIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN THE NETHERLANDS

被引：0
|
作者：
Kvamme, I [1 ]
de Graaf, G. [1 ]
Nekerman, S. [2 ]
Gijsbers, S. [2 ]
Wester, V [3 ]
Hoogendoorn, M. [1 ]
机构：
[1] Inst Med Technol Assessment, Rotterdam, Netherlands
[2] AstraZeneca, The Hague, Netherlands
[3] Erasmus Univ, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE583
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
    Zueger, Patrick M.
    Kumar, Varun M.
    Harrington, Rachel L.
    Rigoni, Gianna C.
    Atwood, Alicia
    DiDomenico, Robert J.
    Touchette, Daniel R.
    [J]. PHARMACOTHERAPY, 2018, 38 (05): : 520 - 530
  • [42] Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States
    Reifsnider, Odette S.
    Tafazzoli, Ali
    Linden, Stephan
    Ishak, Jack
    Rakonczai, Pal
    Stargardter, Matthew
    Kuti, Effie
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [43] Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice
    Montero-Perez-Barquero, Manuel
    Escobar-Cervantes, Carlos
    Arevalo-Lorido, Jose Carlos
    Conde-Martel, Alicia
    Salamanca-Bautista, Prado
    Manzano-Espinosa, Luis
    Formiga, Francesc
    Diez-Manglano, Jesus
    Cepeda, Jose Maria
    Gonzalez-Franco, Alvaro
    Casado-Cerrada, Jesus
    [J]. FUTURE CARDIOLOGY, 2023, 19 (06) : 343 - 351
  • [44] A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
    Tafazzoli, Ali
    Reifsnider, Odette S.
    Bellanca, Leana
    Ishak, Jack
    Carrasco, Marc
    Rakonczai, Pal
    Stargardter, Matthew
    Linden, Stephan
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (09): : 1441 - 1454
  • [45] A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
    Ali Tafazzoli
    Odette S. Reifsnider
    Leana Bellanca
    Jack Ishak
    Marc Carrasco
    Pal Rakonczai
    Matthew Stargardter
    Stephan Linden
    [J]. The European Journal of Health Economics, 2023, 24 : 1441 - 1454
  • [46] Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction
    Sandhu, Alexander T.
    Ollendorf, Daniel A.
    Chapman, Richard H.
    Pearson, Steven D.
    Heidenreich, Paul A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2016, 165 (10) : 681 - +
  • [47] Cost-Effectiveness of Medical Therapy for Heart Failure With Mildly Reduced and Preserved Ejection Fraction
    Dixit, Neal M.
    Truong, Katie P.
    Vaduganathan, Muthiah
    Ziaeian, Boback
    Fonarow, Gregg C.
    [J]. JACC-HEART FAILURE, 2024, 12 (07) : 1226 - 1237
  • [48] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    [J]. Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [49] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [50] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
12345